Jean-François Baurain
0000-0003-4876-4600
Cliniques Universitaires Saint-Luc
1 paper found
Refreshing results…
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors
Missing publications? Search for publications with a matching author name.